Skip to content
Screener

CryoPort, Inc. CYRX Shares (Diluted)

Shares (Diluted) at other companies

Azenta logo
AzentaAZTA
45.3M-1.1%
Cencora logo
CencoraCOR
193.9M-0.7%
BioLife Solutions logo
BioLife SolutionsBLFS
49.3M+3.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
371M-1.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
27M-3.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
48M-2.6%

Other financials

Income statement

See full
Revenue$49.0M+7.7%
Gross profit$22.8M+6.8%
Operating income-$10.0M-4.0%
Net income-$8.3M-108%
EPS (diluted)-$0.20-109%

Balance sheet

See full
Cash & equivalents$269.3M+10.6%
Total debt$232.3M+423%
Total equity$490.7M-5.5%
Total assets$756.2M-2.3%

Cash flow

See full
Operating cash flow$1.1M+115%
CapEx$9.1M+109%
Free cash flow-$8.0M+31.8%

Valuation

See full
Market cap$762.08M+87.9%
Enterprise value$725.12M+251%
P/E9.2×
P/S4.1×+1.6×

Profitability

See full
Gross margin47.1%+0.8pp
Operating margin-21.2%-3.2pp
Net margin41.4%+23.4pp
FCF margin-10.7%-3.4pp

Returns & leverage

See full
Return on equity15.3%+9.1pp
Debt / equity0.5×+0.4×
Current ratio2.1×-14.2×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: CryoPort, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-092107
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Income (loss) from discontinued operations120,883(1,112)115,640
Net income (loss)$(8,255)$108,869$(18,799)$96,888
Paid-in-kind dividend on Series C Preferred Stock(2,000)(2,000)(4,000)(4,000)
Net income (loss) attributable to common stockholders$(10,255)$106,869$(22,799)$92,888
Net loss per share from continuing operations — basic and diluted$(0.20)$(0.28)$(0.43)$(0.45)
Net income (loss) per share from discontinued operations — basic and diluted$2.41$(0.02)$2.31
Net income (loss) per share — basic and diluted$(0.20)$2.13$(0.45)$1.85
Weighted average common shares issued and outstanding — basic and diluted50,442,79650,257,11250,173,73050,102,918

Cover / Front Matter

FAQ

What is CryoPort, Inc.'s shares (diluted)?
CryoPort, Inc. (CYRX) reported shares (diluted) of 50.4M in Q2 2026.
How has CryoPort, Inc.'s shares (diluted) changed year-over-year?
CryoPort, Inc.'s shares (diluted) increased by 0.4% year-over-year, from 50.3M to 50.4M.
What is the long-term trend for CryoPort, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), CryoPort, Inc.'s shares (diluted) has grown at a 2.5% compound annual growth rate (CAGR), from 181.6M to 200.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about CryoPort, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude